| Literature DB >> 9158189 |
C I Perre1, J E Rütter, P A Vos, P de Hooge.
Abstract
In a prospective study the value of technetium-99m-sestamibi scintigraphy (MIBI scintigraphy) in staging axillary lymph node involvement in breast cancer patients was established. The study comprised 36 cases. The results of the staging were compared with physical and histological examination. MIBI scintigraphy had a sensitivity of 91% and a total accuracy of 81%. These percentages demonstrate the potential value of this technique; larger series will be needed to confirm our results.Entities:
Mesh：
Substances：
Year: 1997 PMID： 9158189 DOI： 10.1016/s0748-7983(97)80008-x
Source DB: PubMed Journal: Eur J Surg Oncol ISSN： 0748-7983 Impact factor: 4.424